This Article Full Text Full Text (PDF) All Versions of this Article: 49/2/249    most recent 01.HYP.0000253086.74365.52v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Daghini, E. Articles by Lerman, L. O. Search for Related Content PubMed PubMed Citation Articles by Daghini, E. Articles by Lerman, L. O. Related Collections Remodeling Primary prevention Secondary prevention Cardiovascular imaging agents/Techniques Hypertrophy Imaging CT and MRI

(Hypertension. 2007;49:249.)
© 2007 American Heart Association, Inc.

Brief Reviews

Examine Thy Heart With All Diligence

Evaluation of Cardiac Function Using Fast Computed Tomography

From the Division of Nephrology and Hypertension (E.D., L.O.L.) and Cardiovascular Disease (L.O.L.), Department of Medicine, and the Department of Physiology and Biomedical Engineering (E.D., E.L.R.), Mayo Clinic College of Medicine, Rochester, Minn.

Correspondence to Lilach O. Lerman, Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, 200 First St SW, Rochester, MN 55905. E-mail lerman.lilach@mayo.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Cardiovascular disease is a major cause of mortality in Western society but at its early phase may manifest as subtle alterations in coronary epicardial or microvascular function, including endothelial dysfunction, abnormal perfusion or permeability, and remodeling, which may precede clinical manifestation of vascular disease. These modifications might be associated with subclinical decline in diastolic and/or systolic function and left ventricular (LV) remodeling. Evaluation of myocardial perfusion and microvascular function to identify areas of persistent ischemia or hibernating myocardium, endothelial, or LV dysfunction is, therefore, important for clinical decision-making and fuels the search for noninvasive techniques assessing different stages of cardiac disease.

Several noninvasive or minimally invasive techniques currently used to explore cardiac function, such as echocardiography, scintigraphy, and single-photon emission computed tomography, show diagnostic reliability but low spatial resolution and poor anatomic details. Therefore, higher-resolution techniques, like positron emission tomography, MRI, and computed tomography (CT), have been steadily gaining popularity.¹ MRI can assess cardiac function, mass, volume, and myocardial viability, with limited application in patients with metal fragments, and positron emission tomography provides reliable estimates of myocardial perfusion and metabolism, albeit at low spatial resolution. Furthermore, since its inception in the 1970s, CT quickly incorporated into clinical practice, and recent technical advances have placed it in the forefront for comprehensive evaluation of cardiac function at several levels, from the function of the heart as a pump, to the behavior of the microvessels that feed its walls (Figure 1). For example, CT overcomes some of the limitations of MRI, . . . [Full Text of this Article]